Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Cleantech Building Materials	LSE:CBM	London	Ordinary Share	GB00BV1VRR47	ORD GBP0.01

Share Name

Share Symbol

Market

Type

Share ISIN

Share Description

Cleantech Building Materials

LSE:CBM

London

Ordinary Share

GB00BV1VRR47

ORD GBP0.01

Price Change

% Change

Share Price

Bid Price

Offer Price

High Price

Low Price

Open Price

Shares Traded

Last Trade

0.00

0.00%

7.875

0.00

00:00:00

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
	0	0		N/A	0

Industry Sector

Turnover

Profit

EPS - Basic

PE Ratio

Market Cap

N/A

Cambrex Continuous-Flow Microwave-Assisted Organic Synthesis Technology Nominated for 2009 Innovations Award

16/09/2009 11:16pm

PR Newswire (US)

Cleantech (LSE:CBM)
Historical Stock Chart

From Jan 2020 to Jan 2025

EAST RUTHERFORD, N.J., Sept. 16 /PRNewswire-FirstCall/ -- Cambrex Corporation (NYSE:CBM) announced today that its Continuous-Flow Microwave-Assisted Organic Synthesis (CF-MAOS) technology has been accepted as a nominee for the 2009 Innovations Awards at CPhI, an important upcoming pharmaceutical ingredients exhibition to be held in Madrid, Spain. The CF-MAOS technology represents a dual technological breakthrough, allowing both the scale-up of microwave-assisted chemistry and the handling of heterogeneous mixtures in continuous-flow. This new technology will finally bring the benefits of both technologies out of the laboratory and into production. The CaMWave(TM) KiloLAB flow reactor is capable of manufacturing in excess of 20 kilograms of product per day, and combined with larger reactors, can generate more than one hundred metric tons of product per year. This versatile technology facilitates faster, cleaner, more reliable reactions, leading to improved productivity and lower manufacturing costs. The technology will be presented during the CPhI Innovation Awards: Title: Microwave Chemistry - Out of the Lab and Into Production Speaker: Dr. Jayne E. Muir Date: October 13, 2009 Location: Hall 10, Stand 10G16 Time: 11:00-11:20 a.m. Visit Cambrex at CPhI in Madrid at Feria de Madrid Hall 3, Stand 3C70 on October 13-15, 2009. About Cambrex Cambrex provides products and services to accelerate the development and commercialization of small molecule therapeutics including active pharmaceutical ingredients ("API"), advanced intermediates, enhanced drug delivery, and other products for branded and generic pharmaceuticals. For more information, please visit http://www.cambrex.com/. DATASOURCE: Cambrex Corporation CONTACT: Stephanie LaFiura, Investor Relations Associate, +1-201-804-3037, Web Site: http://www.cambrex.com/

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

CBM Cleantech Building Materials